(Press-News.org) Study effectively reduced doctors’ actions for overused tests and treatment
Routine testing for prostate cancer, urinary tract infections and blood sugar can result in unnecessary care and serious health problems
Practices stubbornly persist despite lack of evidence
CHICAGO --- When a doctor ordered a routine prostate screening for an 80-year-old man — as doctors often do — a dramatic yellow alert popped up on the electronic health record with dire warnings.
It flashed: “You are ordering a test that no guideline recommends. Screening with PSA can lead to harms from diagnostic and treatment procedures. If you proceed without a justification, the unnecessary test will be noted on the health record.”
This was the strategy Northwestern Medicine investigators tested to see if they could move the needle on the stubbornly persistent practice of ordering unnecessary screenings for older adults. Doctors got the message.
The results, published Feb. 6 in Annals of Internal Medicine, found a significant decrease in screenings for prostate cancer and urinary tract infections.
After 18 months of delivering the alerts to 370 clinicians in 60 Northwestern Medicine clinics, unnecessary testing was reduced 9% in the PSA intervention group and 5.5% in the urine testing intervention group. There was, however, only a small change, in the overtreatment of blood sugar, which also can result in potential harm. Half of the physicians received the alerts, the other half did not.
“To our knowledge, this is the first study to significantly reduce all of the unnecessary testing or treatments studied using point-of-care alerts,” said lead investigator Dr. Stephen Persell, a professor of medicine at Northwestern University Feinberg School of Medicine and a Northwestern Medicine physician. “We believe that incorporating elements like a focus on potential harms, sharing social norms and promoting a sense of social accountability and reputational concerns led to the effectiveness of these messages.”
Several recent trials that attempted to reduce overuse of testing, using interventions delivered to clinicians through the electronic health record, have not been particularly successful at changing clinicians’ behavior, Persell noted.
“But if messages clinicians find compelling can be delivered by electronic health records at the time clinicians place their orders, this could be a straightforward way to improve care and could be applied across large health systems easily,” Persell said.
Harm from unnecessary screening and overtreatment
Screening a man 76 years or older for prostate cancer may result in overtreatment that could cause him serious health problems than simply living with an indolent cancer.
Even so, a man’s primary care physician will often obtain a PSA test to screen for prostate cancer. Ditto for women 65 and older being tested for urinary tract infections without any symptoms. Doctors also overtreat diabetes with hypoglycemic agents in patients aged 75 years and older.
The overuse of low-value screenings and unnecessary care remains a problem in American health care, particularly for older adults.
“These are screening practices people have adopted without good evidence,” Persell said.
“If a man is not going to live another 10 or 15 years due to his age, you won’t save his life from prostate cancer by screening him, but you will subject him to the potential harms of treatment,” said Persell, also director of the Center for Primary Care Innovation at Feinberg. The treatment may lead to surgery or radiation treatment that can cause urinary incontinence or urinary symptoms, impair sexual function or cause rectal bleeding.
“What’s right for a 68-year-old man might not be right for one who is 75 or 85 years old,” Persell said.
Harm can also result from testing women 65 and older for urinary tract infections, if they are not experiencing any symptoms.
“These asymptomatic urinary tract infections are common in older women, but there is no evidence that you can improve a woman’s health with antibiotics,” Persell said. Antibiotics, however, can cause allergic reactions, diarrhea and antibiotic resistance, which could make bacterial infections harder to treat in the future.
In addition, treating blood sugar to very low levels in older adults with drugs like insulin or sulfonylureas puts older patients at risk for dangerous low blood sugar events.
But doctors and patients resist change in blood sugar interventions. “We have taught patients to strive to control their blood sugar, even when it gets to a point when it’s safer to have slightly less controlled blood sugar,” Persell said. “It’s hard to convince patients and doctors to change their goals.”
The next step in the research and other ongoing studies are testing whether similar approaches can be used to improve the quality of care in other areas where treatments may be overused such as opioids, sleeping pills and drug combinations that may cause harm.
Other authors include Lucia C. Petito, Ji Young Lee, Daniella Meeker, Jason N. Doctor, Noah J. Goldstein, Craig R. Fox, Theresa A. Rowe, Dr. Jeffrey A. Linder, Ryan Chmiel, Yaw Amofa Peprah and Tiffany Brown.
The title of the article is “Reducing Care Overuse in Older Patients Using Professional Norms and Accountability.”
The research was supported by National Institute on Aging of the National Institutes of Health award R33AG057383.
If you’re pregnant, you may want to think twice before making a hamburger run or reaching for a prepackaged pastry, according to research published last month in the journal Environmental International.
Oddly enough it’s not the food that the report targets — not the fries, burgers or even the shakes and cakes — but what touches the food before you eat it.
Research shows that phthalates, a class of chemicals associated with plastics, can shed from the wrapping, packaging and even from plastic gloves worn by food handlers into food. Once consumed during pregnancy, the chemicals can get into the bloodstream, through ...
The U.S. Department of Defense (DoD) awarded a $5 million grant to the University of Texas Rio Grande Valley (UTRGV)-led America’s Additive Foundry Consortium, which includes the University of Houston as a key partner. This is one of six grants – totaling about $30 million – to help enhance national security through community investments.
The funding will enable the consortium to undertake a $7.5 million project designed to ensure that the U.S. military has a stable supply of domestically produced, high-quality tactical alloys critical for national defense. The ...
One vision for the future of computing involves using ripples in magnetic fields — called magnons — as a basic mechanism. In this application, magnons would be comparable to electricity as the basis for electronics.
In conventional digital technologies, such magnonic systems are expected to be far faster than today’s technologies, from laptops and smartphones to telecommunications. In quantum computing, the advantages of magnonics could include not only quicker speeds but also more stable devices.
A recent study in the journal Nature Physics reports an early-stage discovery along the path ...
Africa’s rice sector has major opportunities to increase its yield gains through improved agronomic practices while avoiding massive land conversion, a study by international scientists including a Husker co-investigator finds. The production advances can be important in meeting Africa’s projected food needs and reducing dependence on imports, the researchers concluded.
Rice demand in Africa is projected to more than double over the next 25 years due to population growth and increased rice consumption. At present, Africa imports nearly 40% of its rice.
“Nearly 15 million hectares of rice are waiting for yield improvement in Africa, ...
“The findings validate the combined PROX1/α-SMA gene set as a prospective prognostic biomarker and a central regulator in CRC progression and its TME.”
BUFFALO, NY- February 7, 2024 – A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 16, Issue 2, entitled, “PROX1 interaction with α-SMA-rich cancer-associated fibroblasts facilitates colorectal cancer progression and correlates with poor clinical outcomes and therapeutic resistance.”
The tumor microenvironment (TME) plays a vital role in tumor progression through intricate ...
UNIVERSITY PARK, Pa. — Rocks once buried deep in ancient subduction zones — where tectonic plates collide — could help scientists make better predictions of how these zones behave during the years between major earthquakes, according to a research team from Penn State and Brown University.
Clues from rock formations in Alaska and Japan allowed the scientists to develop a new model to predict the pressure solution activity in subduction zones, the researchers reported in the journal Science Advances. ...
The Michael J. Fox Foundation for Parkinson’s Research has chosen MUSC as one of four sites for the Black and African American Connections to Parkinson’s Disease (BLAAC PD) research study, a part of the Global Parkinson’s Genetics Program.
BLAAC PD will explore the genetic basis of Parkinson’s disease (PD) in the Black community by genotyping more than 150,000 people worldwide, setting the stage for the development of targeted treatments. According to the Parkinson’s Foundation, approximately 36,265 people with ...
The American Society of Heating, Refrigeration and Air-Conditioning Engineers, or ASHRAE, selected Jason DeGraw, a researcher with the Department of Energy’s Oak Ridge National Laboratory, as one of 23 members elevated to Fellow during its 2024 winter conference.
A thermal-fluid scientist and mechanical engineer in the Thermal Energy Storage group, DeGraw was recognized for making substantial contributions in heating, ventilation, air-conditioning and refrigeration, and the built environment. He contributes education, research, engineering design and consultation, publications, presentations and mentoring to ASHRAE. At ORNL, DeGraw works with the Building Technologies ...
(Memphis, Tenn. – February 7, 2024) St. Jude Children’s Research Hospital today announced Sara M. Federico, MD, has been named director of the institution’s Solid Tumor Division within the Department of Oncology. Federico is an internationally recognized leader in pediatric oncology whose contributions have defined the landscape of treatment for high-risk childhood solid tumors, such as neuroblastoma.
“Dr. Federico’s experience will pave the way for new discoveries that will help advance cure rates for patients with high-risk cancers by identifying, testing and optimizing novel therapeutic strategies,” said Julie R. ...
INDIANAPOLIS – Pioneering cancer researcher Craig B. Thompson, MD, has been named the 2024 winner of the August M. Watanabe Prize in Translational Research.
Awarded by the Indiana University School of Medicine, the Watanabe Prize is one of the nation's largest and most prestigious awards recognizing individuals focused on shepherding scientific discoveries into new therapies for patients. The prize is awarded to a senior investigator who has made a significant contribution to the field of translational science.
Thompson is the former president and chief executive officer ...